Edition:
United Kingdom

Capricor Therapeutics Inc (CAPR.OQ)

CAPR.OQ on NASDAQ Stock Exchange Capital Market

0.43USD
15 Feb 2019
Change (% chg)

$0.02 (+3.73%)
Prev Close
$0.41
Open
$0.41
Day's High
$0.44
Day's Low
$0.41
Volume
55,174
Avg. Vol
41,741
52-wk High
$1.99
52-wk Low
$0.31

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.22 -0.135
Jun '18 0.40 -0.142
Mar '18 0.40 -0.136
FY 2017 Dec '17 0.48 0.306
Sep '17 0.31 -0.117
Jun '17 1.00 -0.157
Mar '17 0.88 -0.171
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 2 0.65 1.30 0.00 2.90
Earnings (per share)
Year Ending Dec-19 2 -0.50 -0.50 -0.50 -0.61
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.44 33.70
P/E High - Last 5 Yrs. -- 147.79 49.87
P/E Low - Last 5 Yrs. -- 47.97 24.25
Beta -2.65 1.08 0.90
Price to Sales (TTM) 19.03 49.51 6.29
Price to Book (MRQ) -- 10.14 5.26
Price to Tangible Book (MRQ) -- 13.78 6.77
Price to Cash Flow (TTM) -- 56.20 24.98
% Owned Institutions 3.23 3.74 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.85
Payout Ratio(TTM) -- 7.02 41.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -11.80 205.92 12.75
Sales (TTM) vs TTM 1 Yr. Ago -26.18 48.79 5.84
Sales - 5 Yr. Growth Rate 24.17 22.76 11.23
EPS (MRQ) vs Qtr. 1 Yr. Ago 39.94 75.85 47.15
EPS (TTM) vs TTM 1 Yr. Ago 8.12 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.85
Capital Spending - 5 Yr. Growth Rate 149.85 9.07 15.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.25
Current Ratio (MRQ) 0.82 3.50 3.08
LT Debt to Equity (MRQ) -- 18.65 11.38
Total Debt to Equity (MRQ) -- 31.33 16.12
Interest Coverage (TTM) -58.74 -43.11 29.47

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.24 53.81
Gross Margin - 5 Yr. Avg. -- 60.48 52.18
EBITD Margin (TTM) -423.45 -- --
EBITD - 5 Yr. Avg -265.04 -110.40 12.87
Operating Margin (TTM) -470.06 -184.63 6.20
Operating Margin - 5 Yr. Avg. -287.51 -126.89 8.31
Pre-Tax Margin (TTM) -481.18 -175.33 7.16
Pre-Tax Margin - 5 Yr. Avg. -292.39 -132.68 8.61
Net Profit Margin (TTM) -481.18 -182.03 3.30
Net Profit Margin - 5 Yr. Avg. -292.39 -137.07 4.89
Effective Tax Rate (TTM) -- 22.48 22.91
Effective Tax Rate - 5 Yr. Avg. -- 15.51 23.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,654,601 842,398,385
Net Income/Employee (TTM) -- 562,114 99,842,801
Receivable Turnover (TTM) 13.29 6.23 5.71
Inventory Turnover (TTM) -- 1.89 3.47
Asset Turnover (TTM) 0.25 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -120.88 6.39 11.06
Return on Assets - 5 Yr. Avg. -96.30 5.47 12.20
Return on Investment (TTM) -645.84 8.92 14.45
Return on Investment - 5 Yr. Avg. -149.85 6.78 15.87
Return on Equity (TTM) -- 10.08 15.96
Return on Equity - 5 Yr. Avg. -- 8.32 17.00
  1 Year 3 Year 5 Year
Sales % -27.53 99.55 24.17
EPS (TTM) % -25.39 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Capricor Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 177.67 168.10 99 99
13 Week 326.87 306.08 99 95
26 Week -0.69 -8.24 99 98
52 Week -15.13 -28.07 78 72
YTD 7.52 -5.58 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 5.35%
# of Holders: 22
Total Shares Held: 1,660,959
3 Mo. Net Change: -527,643
# New Positions: 2
# Closed Positions: 3
# Increased Positions: 5
# Reduced Positions: 8
# Net Buyers: -3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.